Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | NMI's Dr. Torchilin Named Recipient of the Journal of Drug Targeting’s Lifetime Achievement AwardNMI's Co-Founder Dr. Torchilin was named the recipient of the Journal of Drug Targeting’s Lifetime Achievement Award for 2012 for his work in multifunctional pharmaceutical nanocarriers.
By: Nemucore Medical Innovations, Inc. About Nemucore Medical Innovations, Inc. Nemucore Medical Innovations, Inc. is dedicated to designing, investigating, developing, and commercializing life-saving nanomedicines for the treatment of ovarian cancer. Ultimately, we believe our products will be part of the personalized medicine revolution occurring in cancer therapies. Our unique focus on reducing the complex nature of nanomedicine manufacturing is expected to enhance the speed by which we translate novel therapeutics to the clinic. As a participant in the National Cancer Institute's Centers for Cancer Nanotechnology Excellence, we are building a state of the art biomanufacturing facility as a national resource for nanomedicine and emerging biopharmaceutical community. NMI was founded in 2008 and is based in Worcester and Wellesley, Massachusetts. For more information, please visit http://www.nemucore.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|